Xenetic Biosciences XBIO Cash Flow Statement (2011-2026)

NASDAQ XBIO
$3.39 +0.03 (+0.89%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-1.35M-1.88M-33.42M-35.29M-33.65M-1.59M-39.62M-40.20M-40.35M-1.26M-41.37M-41.74M-41.10M-1.10M-42.30M-42.32M-42.24M-0.62M-40.36M-41.13M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
0.11M0.11M0.12M0.14M0.14M0.12M0.07M0.07M0.07M0.07M0.08M0.04M0.03M0.03M0.02M0.02M0.02M0.01M0.01M0.05M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-1.03M-1.46M-2.09M-0.73M-1.08M-0.75M-1.10M-1.27M-0.95M-0.79M-1.16M-0.53M-0.46M-0.67M-1.00M-0.38M-0.66M-0.24M-0.54M-0.88M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
0.01M0.01M0.01M0.01M0.01M
Depreciation & Amortization (CF) (Quarter)
-0.03M
Change in Working Capital
Change in Receivables (Quarter)
0.06M-0.35M0.26M-0.27M-0.12M0.24M0.32M0.44M0.16M-0.88M-0.05M0.16M-0.53M0.23M-0.11M0.26M0.37M-0.78M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
0.16M0.30M-0.36M0.22M-0.23M0.02M-0.22M0.01M0.20M-0.26M-0.09M0.87M-0.58M-0.12M-0.23M0.24M0.21M-0.14M-0.01M-0.06M
Other Working Capital Changes (Quarter)
-0.11M0.08M-0.07M
Investing Activities
Capital Expenditures (Quarter)
0.39M0.00M-0.00M0.31M-0.34M-0.22M-0.14M0.31M-0.70M0.31M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)
0.00M
Cash from Financing Activities (Quarter)
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
10.42M-1.46M-2.09M-1.23M-1.08M-0.75M-1.10M-1.27M-0.95M-0.79M-1.16M-0.53M-0.46M-0.67M-1.00M-0.38M-0.66M3.76M-0.54M-0.88M
Free Cash Flow (Quarter)
-1.03M-1.85M-2.09M-0.73M-1.39M-0.41M-0.88M-1.13M-0.95M-1.11M-1.16M-0.53M-0.46M0.03M-1.00M-0.38M-0.66M-0.56M-0.54M-0.88M
Net Cash Flow (Quarter)
-1.03M-1.46M-2.09M-0.73M-1.08M-0.75M-1.10M-1.27M-0.95M-0.79M-1.16M-0.53M-0.46M-0.67M-1.00M-0.38M-0.66M-0.24M-0.54M-0.88M